Tibra Equities Europe’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-64,100
Closed -$9.49M 208
2020
Q3
$9.49M Buy
+64,100
New +$9.92M 2% 15
2019
Q4
Sell
-27,900
Closed -$3.12M 256
2019
Q3
$3.12M Buy
27,900
+9,500
+52% +$1.06M 0.38% 51
2019
Q2
$2.04M Sell
18,400
-146,600
-89% -$17.3M 0.15% 116
2019
Q1
$21.4M Buy
165,000
+143,900
+682% +$17.5M 2.14% 9
2018
Q4
$2.44M Buy
+21,100
New +$2.36M 0.4% 47
2018
Q3
Sell
-33,416
Closed -$2.85M 228
2018
Q2
$2.85M Buy
+33,416
New +$2.74M 0.43% 57

Other funds holding LLY

Tibra Equities Europe's LLY Position: Q4 2020 in Review

Tibra Equities Europe sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 64,100 shares — an estimated $9.49M sold.

Tibra Equities Europe first reported a position in LLY in Q2 2018 and held it in 6 quarters. The position peaked at $21.4M in Q1 2019. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Tibra Equities Europe reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
  • Tibra Equities Europe sold 64,100 Eli Lilly shares in Q4 2020, an estimated $9.49M.
  • Tibra Equities Europe first reported a position in Eli Lilly in Q2 2018 and held it in 6 quarters.
  • Tibra Equities Europe's Eli Lilly position peaked at $21.4M in Q1 2019.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Tibra Equities Europe's 13F filing for Q4 2020, filed 12 Feb 2021.